Sort by
Refine Your Search
-
student passionate about developing novel therapeutics for brain diseases such as stroke and Alzheimer’s disease. The project focuses on understanding how the brain vasculature—particularly the blood-brain
-
) is the most malignant primary brain tumour, representing approximately half of all primary central nervous system malignancies. It is a rapidly developing tumour seen in patients with an average age of
-
to execute and costly to implement. Therefore, new population-level strategies, targeting whole communities, are urgently needed. This project aims to develop a new toolkit to promote dementia risk reduction
-
the ARC Research Hub for Value-Added Processing of Underutilised Carbon Waste, which is established in 2024 with the aim for developing advance upcycling technologies and associated regulatory and social
-
the World Mental Health International College Student Initiative (WMH-ICS), researchers at Curtin University have developed an assessment, triage, and assertive outreach system that has been shown to reduce
-
novel opportunity to automate and improve the frailty assessment process, aiming for greater consistency and predictive accuracy. Aims i) Develop a deep learning algorithm to autonomously detect and
-
underlying multisensory learning. Develop and test protocols for multisensory stimulation that can be applied in clinical environments. Assess the feasibility and effectiveness of these protocols in real-world
-
and Development package of $13,000 per annum. In addition, this program offers: A 60-day Industry Engagement component with the industry partner (Gold Hydrogen Limited), and A structured professional
-
of microbial biofilms, extrapolymeric substances and metabolic activities under a range of substrate conditions. This project aims to significantly advance the current perceptions and knowledge by developing new
-
, there is an urgent demand for accurate data on ion-beam collisions with atomic and molecular targets for the development and maintenance of fusion reactors, treatment planning in hadron therapy, and